Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Phillip R. Pittman, David McClain, Xiaofei Quinn, Kevin M. Coonan, Joseph Mangiafico, Richard S. Makuch, John Morrill, Clarence J. Peters
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans'. Together they form a unique fingerprint.